Characterizing the Clinical and Genetic Spectrum of Polycystic Ovary Syndrome in Electronic Health Records
- PMID: 32961557
- PMCID: PMC7765638
- DOI: 10.1210/clinem/dgaa675
Characterizing the Clinical and Genetic Spectrum of Polycystic Ovary Syndrome in Electronic Health Records
Abstract
Context: Polycystic ovary syndrome (PCOS) is one of the leading causes of infertility, yet current diagnostic criteria are ineffective at identifying patients whose symptoms reside outside strict diagnostic criteria. As a result, PCOS is underdiagnosed and its etiology is poorly understood.
Objective: We aim to characterize the phenotypic spectrum of PCOS clinical features within and across racial and ethnic groups.
Methods: We developed a strictly defined PCOS algorithm (PCOSkeyword-strict) using the International Classification of Diseases, ninth and tenth revisions and keywords mined from clinical notes in electronic health records (EHRs) data. We then systematically relaxed the inclusion criteria to evaluate the change in epidemiological and genetic associations resulting in 3 subsequent algorithms (PCOScoded-broad, PCOScoded-strict, and PCOSkeyword-broad). We evaluated the performance of each phenotyping approach and characterized prominent clinical features observed in racially and ethnically diverse PCOS patients.
Results: The best performance came from the PCOScoded-strict algorithm, with a positive predictive value of 98%. Individuals classified as cases by this algorithm had significantly higher body mass index (BMI), insulin levels, free testosterone values, and genetic risk scores for PCOS, compared to controls. Median BMI was higher in African American females with PCOS compared to White and Hispanic females with PCOS.
Conclusions: PCOS symptoms are observed across a severity spectrum that parallels the continuous genetic liability to PCOS in the general population. Racial and ethnic group differences exist in PCOS symptomology and metabolic health across different phenotyping strategies.
Keywords: electronic health record; hormones; phenotyping; polycystic ovary syndrome; polygenic risk scores.
© Endocrine Society 2020.
Figures
References
-
- Teede H, Gibson-Helm M, Norman RJ, Boyle J. Polycystic ovary syndrome: perceptions and attitudes of women and primary health care physicians on features of PCOS and renaming the syndrome. J Clin Endocrinol Metab. 2014;99(1):E107-E111. - PubMed
-
- Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19-25. - PubMed
-
- Azziz R, Carmina E, Dewailly D, et al. ; Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society . The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456-488. - PubMed
-
- Indran IR, Huang Z, Khin LW, Chan JKY, Viardot-Foucault V, Yong EL. Simplified 4-item criteria for polycystic ovary syndrome: a bridge too far? Clin Endocrinol (Oxf). 2018;89(2):202-211. - PubMed
Publication types
MeSH terms
Grants and funding
- T32 GM007628/GM/NIGMS NIH HHS/United States
- U54 MD010722/MD/NIMHD NIH HHS/United States
- U19 HL065962/HL/NHLBI NIH HHS/United States
- S10 RR025141/RR/NCRR NIH HHS/United States
- R01 HD074711/HD/NICHD NIH HHS/United States
- RC2 GM092618/GM/NIGMS NIH HHS/United States
- U01 HG006378/HG/NHGRI NIH HHS/United States
- R25 GM059994/GM/NIGMS NIH HHS/United States
- T32 DK007061/DK/NIDDK NIH HHS/United States
- UL1 TR000445/TR/NCATS NIH HHS/United States
- 2020063/DDCF/Doris Duke Charitable Foundation/United States
- P50 GM115305/GM/NIGMS NIH HHS/United States
- UL1 RR024975/RR/NCRR NIH HHS/United States
- R01 NS032830/NS/NINDS NIH HHS/United States
- U01 HG004798/HG/NHGRI NIH HHS/United States
- UL1 TR002243/TR/NCATS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
